Evidence map›Paper›PMID 35042968›Full record

ReviewNature reviews. Endocrinology2022

Primary hypothyroidism and quality of life.

Laszlo Hegedüs, Antonio C Bianco, Jacqueline Jonklaas, Simon H Pearce, Anthony P Weetman, Petros Perros

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 2 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Treatment Preferences in Patients With Hypothyroidism.The Journal of clinical endocrinology and metabolism · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Laszlo HegedüsDepartment of Endocrinology, Odense University Hospital, Odense, Denmark. laszlo.hegedus@rsyd.dk.
Antonio C BiancoSection of Adult and Paediatric Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7737-6813
Jacqueline JonklaasDivision of Endocrinology, Georgetown University, Washington, DC, USA.ORCID http://orcid.org/0000-0002-2238-2666
Simon H PearceTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Anthony P WeetmanDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Petros PerrosDepartment of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Royal Victoria Infirmary · GBGeorgetown University · USOdense University Hospital · DKUniversity of Chicago · USUniversity of Sheffield · GB

Funding

Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
SELENODEIODINAS PROCESSING BY THE PROTEASOME SYSTEMR01DK058538 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BIANCO, ANTONIO C, GEREBEN, BALÁZS · 2001 to 2024
$6.0M
Thyroid-adrenergic synergism and adaptive thermogenesisR01DK065055 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BIANCO, ANTONIO C · 2005 to 2021
$4.4M
Capturing the Impact of Craniofacial Damage after Radioiodine TherapyR01DE025822 · NIDCR · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D., JONKLAAS, JACQUELINE · 2016 to 2020
$1.3M
Selenodeidinase Processing by the Proteasome SystemR56DK058538 · NIDDK · UNIVERSITY OF CHICAGO · PI BIANCO, ANTONIO C · 2019 to 2019
$203k
Medical Research Council G0500783Medical Research Council MR/V005898/1NCATS NIH HHS UL1 TR001409NIDCR NIH HHS R01 DE025822NIDDK NIH HHS R01 DK058538NIDDK NIH HHS R01 DK065055NIDDK NIH HHS R56 DK058538
6 · The paper itself

Abstract

In the 1970s, treatment with thyroid extract was superseded by levothyroxine, a synthetic L form of tetraiodothyronine. Since then, no major innovation has emerged for the treatment of hypothyroidism. The biochemical definition of subclinical hypothyroidism is a matter of debate. Indiscriminate screening for hypothyroidism has led to overdiagnosis and treatment initiation at lower serum levels of thyroid-stimulating hormone (TSH) than previously. Adverse health effects have been documented in individuals with hypothyroidism or hyperthyroidism, and these adverse effects can affect health-related quality of life (QOL). Levothyroxine substitution improves, but does not always normalize, QOL, especially for individuals with mild hypothyroidism. However, neither studies combining levothyroxine and liothyronine (the synthetic form of tri-iodothyronine) nor the use of desiccated thyroid extract have shown robust improvements in patient satisfaction. Future studies should focus not only on a better understanding of an individual's TSH set point (the innate narrow physiological range of serum concentration of TSH in an individual, before the onset of hypothyroidism) and alternative thyroid hormone combinations and formulations, but also on autoimmunity and comorbidities unrelated to hypothyroidism as drivers of patient dissatisfaction. Attention to the long-term health consequences of hypothyroidism, beyond QOL, and the risks of overtreatment is imperative.

Indexed as

HypothyroidismQuality of LifeHormone Replacement TherapyHumansThyrotropinThyroxineTriiodothyronineThyrotropinThyroxineTriiodothyronine

Identifiers

PMID35042968
PMCPMC8930682
OpenAlexW4205629634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.